期刊文献+

肺癌化疗前后p53表达和细胞凋亡的变化 被引量:5

Clinical Significance of the Expression of Apoptosis and p53 in Lung Cancer
原文传递
导出
摘要 目的 探讨化疗对肺癌细胞凋亡、p5 3蛋白表达的影响。方法 收集实验组 14例肺癌病人化疗前后标本和对照组术前未作化疗肺癌标本 2 8例 ,采用免疫组化法检测p5 3蛋白表达 ,采用TUNEL法检测细胞凋亡 ,并作化疗前后的比较。结果 对照组和实验组在化疗前后p5 3阳性表达无显著差异 (P >0 0 5 ) ,而化疗后凋亡指数明显升高 (P <0 0 1)。结论 化疗可诱发肺癌细胞凋亡 ,但对p5 Objective To determine the effects of pre-operative chemotherapy on p53 expression and apoptosis in lung cancer.Methods 42 patients with lung cancer were divided into pre-opreative chemotherapy group (n=14) and control group (n=28) without preoperative chemotherapy.Method of immunohistochemistry was used to detect the expression of p53 . Terminal deoxynucleotidyl transferase nick end labeling (TUNEL) was used to detect the apoptotic cells.Results The positive rate of p53 expression were as follows;53 5% for control group,64 3% for prechemotherapy group,64 3% for postchemotherapy group respectively;the apoptosis indexes were 6 3±1 9 for control group,7 3±1 6 for prechemotherapy group,14 5±4 6 for postchemotherapy group.Conclusions The preoperative chemotherapy can induce apoptosis in lung cancer ,but can not affect p53 expression .
出处 《中国医师杂志》 CAS 2003年第5期589-591,共3页 Journal of Chinese Physician
关键词 肺癌 化疗 凋亡 P53 Lung neoplasma Chemotherapy Apoptosis p53
  • 相关文献

参考文献14

  • 1李鹏飞,刘耕陶.抗肿瘤新策略──程序性细胞死亡[J].中国药理学通报,1996,12(1):11-14. 被引量:7
  • 2高桥玲 筱原尚.p53遗传因子[J].日本临床,1996,54:1881-1881.
  • 3袁建华,刘子江,罗祖炎,茹国庆,赵仲生,孔颂阳.支气管动脉化疗对非小细胞肺癌细胞凋亡的影响[J].浙江实用医学,1999,4(4):3-5. 被引量:5
  • 4黄伟良,杨莉芳.化疗后肺癌的病理改变和p53表达及其临床意义[J].临床与实验病理学杂志,1999,15(2):187-187. 被引量:1
  • 5Shaw P.Bovery R,Tardy S,et al.Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line[J].Proc Natl Acad Sci USA.1992,89:4495-4499.
  • 6Doyle LA,Machanisms of drug resistance in human lung cancer cells[J].Semin Oncol,1993,20:326-329.
  • 7Ohmori T,Podack ER,Nishio K,et al.Apoptosis of lung cancer cells caused hy some auti-cancer agents is inhibited by bcl-2[J].Bicohem Biophys Res Commune,1993,192:30-36.
  • 8Hichman JA.Apoptosis and chemotherapy resistance[J].Eur J Cancer,1996,30:921-26.
  • 9Lai SL,Pemy RP,Hwang J,et al.p53 gene status modulated the chemosensitivity of non-small cell lung cancer cells[J].J Biomed Sci,2000,7(1):64-70.
  • 10Horio Y,Hasegawa Y,Sekido Y,et al.Synergistic effects of sdenovirus expression wild-type p53 on chemosensitivity of non-small call lung cancer cells[J].Cancer Gene Ther,2000,7(4):537-544.

二级参考文献1

共引文献10

同被引文献24

  • 1彭忠民,陈景寒,王潍博,王晓航.新辅助化疗加手术对Ⅲ期非小细胞肺癌患者预后的影响[J].中国肿瘤临床,2004,31(15):864-866. 被引量:7
  • 2陈福春,陈洪雷,陶鸿潮,张玉霞,叶波,刘铭球.非小细胞肺癌组织p53基因家族成员的不同表达及意义[J].中国肺癌杂志,2004,7(4):339-343. 被引量:1
  • 3杨玲,李连弟,陈育德,D.M.Parkin.中国2000年及2005年恶性肿瘤发病死亡的估计与预测[J].中国卫生统计,2005,22(4):218-221. 被引量:336
  • 4陈胜利,全毅,黄子诚,陈国东,张静,许艳丽.兔VX2肝癌LP-THACE后早期癌细胞凋亡研究[J].医学研究杂志,2006,35(11):39-42. 被引量:4
  • 5Rosell R, Gomez-Codina J, Camps C, et al. Preresectional chemotherapy in stage ⅢA non-small-cell lung cancer: a 7-year assessment of a randomized controlled trial. Lung Cancer,1999,26(1):7-14.
  • 6Felip E, Rosell R. Neoadjuvant chemotherapy in non-small cell lung cancer. Curr Med Chem,2002,9(8):893-898.
  • 7Cheng YL, Lee SC, Harn HJ, et al. Prognostic prediction of the immunohistochemical expression of p53 and p16 in resected non-small cell lung cancer. Eur J Cardiothorac Surg,2003,23(2):221-228.
  • 8Rosell R, Felip E, Maestre J, et al. The role of chemotherapy in early non-small-cell lung cancer management. Lung Cancer,2001,34 Suppl 3:S63-74.
  • 9Dutil EM, Toker A, Newton AC. Regulation of conventional protein kinase C isozymes by phosphoinositide-dependent kinase 1 (PDK-1). Curr Biol,1998,8(25):1366-1375.
  • 10Kawasaki M, Nakanishi Y, Kuwano K, et al. The utility of p53 immunostaining of transbronchial biopsy specimens of lung cancer: p53 overexpression predicts poor prognosis and chemoresistance in advanced non-small cell lung cancer. Clin Cancer Res,1997,3(7):1195-1200.

引证文献5

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部